Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders - Wikidata - awgldk - TriplyDB

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

http://www.wikidata.org/entity/Q33920251

about

The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.Sigma1 receptors inhibit store-operated Ca2+ entry by attenuating coupling of STIM1 to Orai1 Sigma-1 Receptor Agonism Promotes Mechanical Allodynia After Priming the Nociceptive System with Capsaicin.Role of Sigma-1 Receptor in Cocaine Abuse and Neurodegenerative Disease.Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.Sigma1 Pharmacology in the Context of Cancer.Loss of Sigma-1 Receptor Chaperone Promotes Astrocytosis and Enhances the Nrf2 Antioxidant Defense.Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases.The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.

P2860

Q26765995-EDDB4D38-CA3E-4EB0-81AF-8E7C1AE47BF4 Q28392148-1D8F17CB-96BC-4DC0-A02B-5978EB96B498 Q34675713-A8679446-5844-4158-81DB-DAC43B9B47FF Q35669383-B7413D63-3867-4761-81AC-BC247532B838 Q36789920-2EBC8611-1CA4-4623-9239-376EFE9550E0 Q37439130-4E2F05F1-6845-4D91-9E90-30ADC8A28CFD Q38743344-918AB4A9-FBF3-48A4-8092-3456FE0E443A Q38743350-6D11D80A-5ABF-419A-8098-76EBB454D829 Q39458668-1569CA20-4653-440A-8453-9F2AFC356E15 Q41532363-D615AA1B-97B7-4CEA-981A-654E6B84D440 Q41714466-9D9544AD-F9AA-4511-8B89-D8A698D302DA Q50973291-CC02E5C4-29DA-43B4-81C0-70FD46A3B9A8

P2860

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

http://www.wikidata.org/entity/Q33920251

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

@ast

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

@en

type

label

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

@ast

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

@en

prefLabel

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

@ast

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

@en

P1433

Q33920251-6AE546D7-18C1-4252-ACDA-69C9FB1BE450

P1476

Q33920251-DDCEEDD3-DD38-487F-BF56-B7D56E26A0D3

P2093

Q33920251-26275536-CFAA-4543-BBD1-5F4DC2E67DBE

Q33920251-2E3B5D7D-10AA-4A3A-B038-376BD00D9CF2

Q33920251-D9C9F41B-E1A3-402E-BBE7-AE73C97F8BBD

Q33920251-F20F282B-5E51-4A1B-A772-40E70B6E83D5

Q33920251-F481557D-DDF9-46CB-A78A-E12BBECD4617

P2860

Q33920251-006D9AE7-D8A1-4E9A-B8D9-5A88C256FA93

Q33920251-04CAA022-BFFD-4710-96BE-EA5659AF5E75

Q33920251-0954021F-4EEA-49F8-9E96-7E44D25A2C7A

Q33920251-0B68E8AF-49FE-4580-B212-C7441C617AC9

Q33920251-0C3C1638-9848-4868-BB32-E03D1507C678

Q33920251-13D67D4C-BEC0-49F7-9C18-B24607091CF3

Q33920251-1A66EE81-B43D-4D68-A0A0-3A8B936458D2

Q33920251-1B1D717C-1041-490A-ADE4-83813754423F

Q33920251-1CA2A564-653A-478A-8D55-F22B6597B526

Q33920251-1DEB9DAC-F054-4B60-8CD1-E97E4B87D456

P304

Q33920251-F5FA73F6-9D87-44D5-B0AE-F6FF914D4490

P31

Q33920251-9C30C175-882A-4F92-B9CB-75D25E6E1CA7

P356

Q33920251-036EA3C3-429F-4353-A941-9A27F770EA30

P407

Q33920251-F8AF34E4-9683-4927-A4E0-F727DC12B5B0

P433

Q33920251-24D688A8-A484-403B-9EE7-F7CA9D4B8851

P478

Q33920251-E3D6661F-9FD6-42B2-8C58-5E2A7BE8F659

P577

Q33920251-1438A39B-2E97-4D08-B820-7F108F543058

P698

Q33920251-EE830D16-BB32-4199-8D83-D0385E0390E1

P921

Q33920251-09862E89-2CE2-4B4A-A572-D8D8005AD8DA

Q33920251-F8F830D9-B083-4E18-8870-2856FE862A05

P932

Q33920251-BD825DA4-EBF0-4A66-B2BA-375FF8E0B979

P356

14728222.2014.972939

P1433

Expert Opinion on Therapeutic Targets

P1476

Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders

@en

P2093

Michael J Pokrass

http://www.w3.org/2001/XMLSchema#string

Neal R Klauer

http://www.w3.org/2001/XMLSchema#string

Nicole E De Credico

http://www.w3.org/2001/XMLSchema#string

Shang-Yi A Tsai

http://www.w3.org/2001/XMLSchema#string

Tsung-Ping Su

http://www.w3.org/2001/XMLSchema#string

P2860

Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis

A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis

Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis

The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism

Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing

Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior

No association between the sigma receptor type 1 gene and schizophrenia: results of analysis and meta-analysis of case-control studies

Nonmotor symptoms in Parkinson's disease: expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem

Inflammation and Alzheimer's disease

Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters

P304

1461-1476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2014.972939

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25331742

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

molecular chaperones

P932

5518923

http://www.w3.org/2001/XMLSchema#string